JAKARTA has launched human trials of a Chinese-made coronavirus vaccine with some 1,600 volunteers slated to take part in the six-month study.
The vaccine candidate, produced by Sinovac Biotech, is among just a few in the world to enter Phase 3 clinical trials, or large-scale testing on humans – the last step before regulatory approval.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!